IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 29 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,359 | -6.9% | 2,382 | +50.6% | 0.00% | – |
Q2 2023 | $4,683 | +57.5% | 1,582 | +182.0% | 0.00% | – |
Q4 2022 | $2,973 | -81.4% | 561 | -86.2% | 0.00% | – |
Q3 2022 | $16,000 | +128.6% | 4,061 | +118.2% | 0.00% | – |
Q2 2022 | $7,000 | -61.1% | 1,861 | -46.3% | 0.00% | – |
Q1 2022 | $18,000 | -87.3% | 3,466 | -84.8% | 0.00% | – |
Q3 2021 | $142,000 | – | 22,778 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 396,425 | $5,927,000 | 0.29% |
Gradient Capital Advisors, LLC | 21,718 | $325,000 | 0.18% |
Hillsdale Investment Management Inc. | 15,200 | $232,000 | 0.02% |
Orion Portfolio Solutions, LLC | 15,821 | $237,000 | 0.01% |
IFP Advisors, Inc | 1,960 | $30,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 300 | $4,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
CITIGROUP INC | 7 | $0 | 0.00% |
MORGAN STANLEY | 2,100 | $31,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 5,900 | $98,000 | 0.00% |